Transparency Market Research’s Post

#NewEpisode | Did you know the global GLP-1 market, including drugs like Ozempic, could exceed $100 billion by 2030? 🌍💡In our latest Tech4Sight episode, we explore how biotech is reshaping weight management and redefining global health. Join Diana Daniels and Glen Travers, CEO & Founder of Diabetology Limited as they discuss: • 🚀 How GLP-1 therapies are transforming obesity and diabetes care. • 🧬 The connection between biotechnology and lifestyle changes. • 💡 The biggest challenges facing the biotech industry—and solutions. • 🔮 Bold predictions for metabolic health and healthcare’s future. This episode is a must-watch for innovators and leaders ready to explore the future of health! 🎧 Tune in now! ▶️ https://bit.ly/4h3H26Z #tech4sight #NewEpisode #Biotechnology #GLP1 #Ozempic #MetabolicHealth #Innovation #Tech4Sight #FutureOfHealthcare #BiotechPodcast #HealthTech #TechPodcast #youtube #spotify #mustwatch #diabetes #insulin #glucose #health #future #obesity

Exciting news from Novelgene Technologies! 🎉 We are thrilled to introduce SEGADO, our latest innovation in Neurotransmitter Hormone testing. 🧪✨ This cutting-edge test utilizes stool and urine samples to analyze both gut microbiota and urine metabolites, enabling a comprehensive understanding of the gut-brain connection. With SEGADO, we’re empowering our clients with more precise insights for advanced health diagnostics and research. 🌱💡 #Neurotransmitters #GutHealth #HormoneTesting #Innovation #NovelgeneTechnologies Let us know if you’d like to tweak it further!

🌍 Today is World Diabetes Day – a day to bring awareness to a global health challenge affecting millions of lives worldwide. At Bevital AS, we are dedicated to advancing health through high-quality biomarker testing, helping healthcare professionals and researchers gain insights that can lead to better prevention, early diagnosis, and improved management of chronic conditions, including diabetes. 📊 Why biomarkers matter: Biomarkers offer essential data, making it easier to detect health risks before symptoms arise and tailor treatment to individual needs. In the context of diabetes, understanding metabolic markers can support proactive care and potentially reduce the risk of complications. 💡 Our mission: We strive to make biomarker analysis accessible and reliable for professionals globally. By empowering researchers and clinicians with precise metabolomics and proteomics data, we contribute to efforts that make a real difference in people’s health journeys. Together, let’s drive innovation and awareness for a healthier future. #WorldDiabetesDay #DiabetesAwareness #Bevital #Biomarkers #Metabolomics #HealthInnovation #PreventiveCare #Research

Discover the future of healthcare with microbiome therapeutics🦠! By understanding and harnessing the power of the trillions of microorganisms living within us, we're paving the way for innovative treatments that can revolutionize our approach to health and wellness. From personalized medicine to targeted therapies, microbiome research holds the key to unlocking new potential in disease prevention and treatment. Explore how these tiny organisms can make a huge impact on our health🔬. #Microbiome #HealthRevolution #Biotech #InnovativeTherapies #FutureOfMedicine #Wellness #PersonalizedMedicine #HealthcareInnovation #LifeSciences #DiseasePrevention

Understanding SIBO (Small Intestinal Bacterial Overgrowth) is essential. For those affected, eating can feel like a trigger, often described as a "poisoned" sensation—yet many are told SIBO doesn’t exist. But here’s what’s happening. The small intestine is highly sensitive, and when undigested proteins and carbohydrates start to ferment there, it can lead to symptoms triggered by the vagus nerve. We offer a test that helps identify if these issues stem from the distal small bowel, proximal colon, or both, guiding targeted treatment. Here’s where it becomes actionable: a positive breath test for SIBO can increase treatment efficacy with Rifaximin by up to 40% compared to negative results. In medicine, this is a significant advantage. By identifying specific biomarkers for hydrogen and methane production, we can better tailor treatments based on individual microbiome profiles. #SIBO #GutHealth #Microbiome #PrecisionMedicine #DigestiveHealth #HealthcareInnovation

https://lnkd.in/d7WNVsDb Dear Researchers, I am into health and well-being research. In this direction, currently, my team is working on Homocysteine. If anyone is interested let me have you in our research activity. Homocysteine is one of the life-threatening blood biomarkers. Each one us after 30 years, every year we need to test and be aware of the sort of deficiencies. It just costs 1000 rupees. A lot of potential health-related research work is going on related to Homocysteine. I do have several reports related to various diseases. *The same biomarker is useful to maintain optimal health and useful for anti-aging as well* *I have created a detailed one-hour session on Homocysteine. I am sure if not for research, this video will be helpful to take care of your health. Please watch and live a healthy life!*

🌟Unlocking the Potential of Ferritin Testing in Liver Disease🍃 🔬 Discover how ferritin, a key iron-storing protein, is transforming the diagnosis and management of liver disease. A recent study highlights its ability to identify liver damage and inflammation, revolutionizing how we approach patient care. 📈 Not only does ferritin testing provide crucial diagnostic insights, but it also offers a valuable tool for monitoring disease progression and assessing treatment efficacy. By tracking ferritin levels over time, healthcare professionals can identify patients at higher risk for liver complications, enabling early intervention and improved outcomes. 🚀 This breakthrough technology is paving the way for more personalized and effective treatments in the fight against liver disease. Embrace the future of liver health today! Welcome to inquire about the products you are interested in.🥰 ❗Abbott's only third-party partner in China.❗ Whatsup Business >> +86 18030218067 Email >> yyfang@wizbiotech.com Company Website >>https://lnkd.in/g_c4s6FP #Wizbiotech #FerritinTesting #LiverDiseaseAdvancements #HealthcareRevolution 💼✨

Will Your Bones Hold Up? 23andMe 's New Report Assesses Osteoporosis Risk 23andMe (Nasdaq: $ME) has launcheda new polygenic risk score (PRS) report for osteoporosis, providing 23andMe+ Premium members with insights into their genetic likelihood of developing the condition. With osteoporosis affecting over 12 million Americans and contributing to 2 million fractures annually, the condition remains underdiagnosed and undertreated. The report, developed through 23andMe's proprietary research database, analyzes thousands of genetic markers to assess risk. While genetics accounts for 60-80% of bone density variability, lifestyle factors such as diet and exercise also play a role. This launch reflects growing consumer demand for personalized health insights and aligns with 23andMe’s expansion into predictive health solutions. As the market for genetic-driven healthcare tools grows, investors are watching how companies like 23andMe continue to commercialize genomic data for consumer and clinical applications. #StocksToWatch #StocksOnTheMove #StocksInNews #investors #daytrader #PRISMMediaWire #PRISMDigitalMedia #23andMe https://lnkd.in/gBRas_9n

🗣️ Watch Davide Risso, MSc, PhD from Tate & Lyle talk about our latest joint publication around the impact of low-/no-calorie #sweeteners on the #gut #microbiome, for the general population and type II diabetes individuals 🗣️ 🔍 Study highlights 🔍 - We looked at a comprehensive list of sweeteners, including tagatose, sorbitol, maltitol, stevia, acesulfame K, and sucralose. - Both healthy and type-II diabetes individuals were considered - We considered the dosing and digestion of each sweetener individually - The study of the gut microbiome relied on the ex vivo SIFR technology, shown to be predictive for clinical outcomes - Its high throughput was used to simulate about 500 experimental conditions 🌟 Conclusion: the low-/no-calorie sweeteners either fostered positive metabolic and compositional changes in the gut or exhibited no effect, underlining the importance of considering the compounds individually 🌟 🎥 Read more and watch the full video online https://lnkd.in/e-XwRcuJ 🎥 #GutMicrobiome #preclinical #research

The miGut-Health researchers have had a productive year and have published two insightful studies advancing our understanding of #IBD and #gut health. 🔬 #1: This study by Jonas Halfvarson and colleagues shows that a combination of proteins measured in blood can be used to predict a diagnosis of #CrohnsDisease. 🧬 #2: This article from Arnau Vich Vila, Rinse Weersma (UMCG) and team highlights how analysing gut #microbiome metabolites – substances produced during metabolism (such as #digestion) – improves our understanding of #IBD and its treatment. Dive deeper into the findings here: https://lnkd.in/ebuYqX-c